Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: Importance to epidemiology

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 4, 2011, Pages 445-450

  Ogwang, Martin D ^a   Zhao, Weiqiang ^b   Ayers, Leona W ^b   Mbulaiteye, Sam M ^c,d  

^a St Mary's Hospital Lacor Uganda   (Uganda)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d DCEG   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CHILD; DEVELOPING COUNTRY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MALE; PATIENT REFERRAL; PUBLIC HEALTH; REPRODUCIBILITY; STATISTICS; UGANDA;

BURKITT LYMPHOMA; CHILD; DEVELOPING COUNTRIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; PUBLIC HEALTH; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; UGANDA;

EID: 79955076846     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM, Wabinga H, Nambooze S. Completeness in an African cancer registry. Cancer Causes Control. 2001;12(2):147-152. (Pubitemid 32165272)
2. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press;
3. Swerdlow SH, Campo E, Harris NL, et al, eds. 2008. World Health Organization Classification of Tumours; vol 2.
4. Wright DH. Cytology and histochemistry of the Burkitt lymphoma. Br J Cancer. 1963;17(1):50-55.
5. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer. 2008;123(11):2658-2663.
6. Brauchli K, O'mahony D, Banach L, Oberholzer M. iPath - a telemedicine platform to support health providers in low resource settings. Sfud Health Technol Inform. 2005; 114:11-17.
7. Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am. 2003; 17(3):673-696. (Pubitemid 36807592)
8. Newton R, Ziegler J, Beral V, et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer. 2001;92(5):622-627. (Pubitemid 32385701)
9. Mutalima N, Molyneux E, Jaffe H, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS ONE. 2008;3(6):e2505.
10. Parkin DM, Garcia-Giannoli H, Raphael M, et al. Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS. 2000;14(18):2929-2936. (Pubitemid 32042757)
11. Campidelli C, Gazzola A, Vitone F, Pileri SA, Tumwine L. HIV infection and c-MYC status in endemic Burkitt lymphoma. Hum Pathol. 2008;39(9):1408-1409.
12. Mwanda WO, Orem), Fu P, et al. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa. J Clin Oncol. 2009;27(21):3480-3488.
13. Engels EA, Mbulaiteye SM, Othieno E, et al. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. Hum Pathol. 2007;38(2):308-314. (Pubitemid 46110846)
14. Tumwine LK, Campidelli C, Righi S, Neda S, Byarugaba W, Pileri SA. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Hum Pathol. 2008;39(6):817-823.
15. Nathwani BN, Sasu SJ, Ahsanuddin AN, Hernandez AM, Drachenberg MR. The critical role of histology in an era of genomics and proteomics: a commentary and reflection. Adv Anat Pathol. 2007;14(6):375-400. (Pubitemid 350307662)
16. Benediktsson H, Whitelaw J, Roy I. Pathology services in developing countries: a challenge. Arch Pathol Lab Med. 2007;131(11):1636-1639. (Pubitemid 350077458)
17. Hutt MS, Burkitt D. Geographical distribution of cancer in East Africa: a new clinicopathological approach. Br Med J. 1965; 2(5464):719-722.
18. Davies JN, Burkitt DP, Dodge OG. Salivary-gland tumors in Uganda. Cancer. 1964;17:1310-1322.
19. Davies JN. Epidemiology of cancer in Africa: some aspects of the cancer situation in Uganda. Proc R Soc Med. 1963;56(7):532-535.
20. Prento P, Lyon H. Commercial formalin substitutes for histopathology. Biotech Histochem. 1997;72(5):273-282. (Pubitemid 28007177)
21. Whitworth JA, Kokwaro G, Kinyanjui S, et al. Strengthening capacity for health research in Africa. Lancet. 2008;372(9649):1590-1593.
22. Fabiani M, Accorsi S, Aleni R, et al. Estimating HIV prevalence and the impact of HIV/AIDS on a Ugandan hospital by combining serosurvey data and hospital discharge records. J Acquir Immune Defic Syndr. 2003;34(11): 62-66. (Pubitemid 37100113)
23. Orem J, Otieno MW, Banura C, et al. Capacity building for the clinical investigation of AIDS malignancy in East Africa. Cancer Detect Prev. 2005;29(2): 133-145.
24. Nsubuga P, White M, Fontaine R, Simone P. Training programmes for field epidemiology. Lancet. 2008;371(9613):630-631. (Pubitemid 351273384)